Controversial COVID-19 Excess Mortality Study Retracted by BMJ Public Health

A controversial 2024 study published in BMJ Public Health regarding excess mortality during the COVID-19 pandemic has been officially retracted by the BMJ Group. The paper was pulled from the scientific record after editors determined it contained “dezinformare cu privire la posibilele cauze ale supramortalităţii” and relied on “o cantitate limitată de lucrări originale”.

The decision to retract the paper marks the most severe level of repudiation in scientific literature. It comes following criticism. The research had suggested that excess mortality persisted across multiple global regions in the years following the peak of the COVID-19 crisis. Critics argued that the paper provided a pretext for unfounded attacks on COVID-19 vaccines. Yet, the authors did not explicitly establish a direct link between vaccinations and heightened death rates.

The methodology used to calculate excess mortality was also questioned. It has been proven that COVID-19 vaccines have saved millions of lives since the start of the crisis. Nevertheless, numerous “vaccino-sceptic” online publications cited the study, claiming it established a direct link between excess mortality and vaccination against COVID-19. This prompted an initial warning from the publisher recommending caution before culminating in the formal retraction.

The Anatomy of a Retraction in Scientific Literature

Retraction is the most severe level of disapproval in scientific literature. According to the official statement from the BMJ Group, the decision to withdraw the 2024 mortality paper was backed by two of the study’s four authors. The retraction also received support from the Princess Máxima Center for pediatric oncology, where three of the four authors are affiliated.

Photo: stiripesurse.ro

The underlying controversy centered on how the authors framed post-peak mortality trends. While the paper questioned the persistence of excess mortality “în pofida implementării măsurilor de izolare şi a vaccinurilor împotriva COVID-19”, the authors requested that policymakers publish more precise data to allow for the analysis of a presumed role of these two elements. By doing so, the study was accused of providing a pretext for unfounded attacks on COVID-19 vaccines.

The BMJ Group’s action follows the investigation of the study by the group and the Princess Maxima Center.

In Plain English: The Clinical Takeaway

• The Retracted Claim: A 2024 study suggested that high death rates persisted globally after the pandemic peak, leading some groups to wrongly blame vaccines.
• Why It Was Pulled: Journal editors and institutional stakeholders found that the paper relied on limited data and contained misinformation regarding mortality causes.
• The Clinical Reality: COVID-19 vaccines have saved millions of lives since the start of the crisis.

Contrasting Institutional Responses and Publishing Standards

The handling of the retracted manuscript highlights the structure of the publisher. BMJ Public Health is a journal specialized in public health, distinct from the British Medical Journal, though both are edited by the same group.

Photo: stiripesurse.ro

Comparison of Retracted Study versus Standard Epidemiological Surveillance

Metric / Parameter	The Retracted 2024 BMJ Public Health Study	Standard Global Health Surveillance
Data Scope	Limited original source material	Not specified in sources
Methodology	Questioned methodology for calculating excess mortality	Not specified in sources
Regulatory Status	Officially retracted by the publisher	Not specified in sources

Institutional backing played a role in bringing about the retraction. The involvement of the Princess Máxima Center, to which three of the four authors are affiliated, supported the decision.

Contraindications & When to Consult a Doctor

Future Directions in Post-Pandemic Surveillance

The retraction of this paper underscores the process of scientific inquiry.

References

• BMJ Group Official Communications and Retraction Notices regarding BMJ Public Health (2024).
• Princess Máxima Center for Pediatric Oncology Institutional Statements on Research Integrity.